Primary peritoneal cancer presenting with widespread lymphadenopathy, radiologically mimicking lymphoma

Primary peritoneal carcinoma (PPC) is a rare malignancy with clinical features and management similar to epithelial ovarian carcinoma (EOC). Lymph node involvement in EOC or PPC is commonly seen in the presence of advanced disease with peritoneal involvement and rarely a presenting symptom. We describe a rare case of PPC in a 74-year-old woman presenting with widespread lymphadenopathy, radiologically mimicking lymphoma without peritoneal involvement. To our knowledge this is the only case of PPC presenting with supraclavicular and widespread lymphadenopathy, in the absence of macroscopic disease. This case may represent a distinct clinical entity from the usual peritoneal dominant form of EOC or PPC and highlights important clinical and biological aspects of PPC.

Primary peritoneal carcinoma; Epithelial ovarian carcinoma; Lymphadenopathy.

[1] Kim Y.M., Lee Y.M., Lee S.H., Lee D.W., Kim K.H.: “Primary peritoneal carcinoma initially presenting as atypical cervical lym-phadenopathy. Case Rep. Oncol., 2015, 8, 246-250.

[2] Eltabbakh G.H., Piver M.S.: “Extraovarian primary peritoneal car-cinoma”. Oncology (Williston Park), 1998, 12, 813-819.

[3] Loh K.P., Ghorab H., Thorne J., Sheikh A., Hill A.: “Primary peritoneal carcinoma: an uncommon entity”. Royal College of Surgeons in Ireland Student Medical Journal. 2011, 4, 28-30.

[4] Hou T., Liang D., He J., Chen X., Zhang Y.: “Primary peritoneal serous carcinoma: a clinicopathological and immunohistochemical study of six cases”. Int. J. Clin. Exp. Pathol., 2013, 5, 762-769.

[5] Mason C., Yokubaitis K., Hamilton R., Oza U., Shah Z., Spigel J., et al.: “Unusual presentation of metastatic ovarian carcinoma as an enlarged intramammary lymph node”. Proc. (Bayl. Univ. Med. Cent.), 2015, 28, 386-388.

[6] Yang X., Zheng F., Xu Y., Ou R.: “Ovarian cancer initially presenting with isolated ipsilateral superficial inguinal lymph node metastasis: a case study and review of the literature”. J. Ovarian Res., 2014, 7, 20.

[7] Eltabbakh G.H., Piver M.S., Hempling R.E., Werness B.A., Blu-menson L.E.: “Importance of lymph node metastases in primary peritoneal carcinoma”. J. Surg. Oncol., 1998, 68, 144-148.

[8] Satti M., Abdelaziz A., Abhari P., Boike G.: “Supraclavicular lymph node as a presentation of fallopian tube cancer. Obstet. Gynecol. Cases Rev., 2016, 3, 94.

[9] Ang D., Ng K., Tan H., Chung A.Y F., Yew B., Lee V.K.M.: “Ovarian carcinoma presenting with isolated contralateral inguinal lymph node metastasis: a case report”. Ann. Acad. Med. Singapore, 2007, 36, 427-430.

[10] Nomoto K., Nakajima T., Miwa S., Hayashi S., Tsuneyama K.: “Pri-mary peritoneal serous papillary carcinoma that metastasized to an axillary lymph node in a woman with a history of breast cancer: A case report and diagnostic pitfalls”. Human Pathology: Case Reports, 2015, 2, 90-93.

[11] Pradeep S., Kim S., Wu S., Nishimura M., Chaluvally-Raghavan P., Miyake T., et al.: “Hematogenous metastasis of ovarian cancer: Rethinking mode of spread”. Cancer Cell, 2014, 26, 77-91.

[12] Pereira E.R., Jones D., Jung K., Padera T.P.: “The lymph node microenvironment and its role in the progression of metastatic cancer”. Semin. Cell Dev. Biol., 2015, 38, 98-105.

[13] Legge F., Petrillo M., Adamo V., Pisconti S., Scambia G., Ferrandina G.: “Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome”. BMC Cancer, 2008, 8, 367.

[14] Bachmann C., Bachmann R., Brucker S.Y., Staebler A., Fend F., Grischke E-M., et al.: “Anticancer research”. 2015, 35, 3479–3484.

[15] Tothill R.W., Tinker A.V., George J., Brown R., Fox S.B., Lade S., et al.: “Novel molecular subtypes of serous and endometriod ovarian cancer linked to clinical outcome”. Clin. Cancer Res., 2008, 14, 5198-5208.